Your browser doesn't support javascript.
loading
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.
Zaman, Azfar; de Winter, Robbert J; Kogame, Norihiro; Chang, Chun Chin; Modolo, Rodrigo; Spitzer, Ernest; Tonino, Pim; Hofma, Sjoerd; Zurakowski, Aleksander; Smits, Pieter C; Prokopczuk, Janusz; Moreno, Raul; Choudhury, Anirban; Petrov, Ivo; Cequier, Angel; Kukreja, Neville; Hoye, Angela; Iniguez, Andrés; Ungi, Imre; Serra, Antonio; Gil, Robert J; Walsh, Simon; Tonev, Gincho; Mathur, Anthony; Merkely, Bela; Colombo, Antonio; Ijsselmuiden, Sander; Soliman, Osama; Kaul, Upendra; Onuma, Yoshinobu; Serruys, Patrick W.
Afiliação
  • Zaman A; Freeman Hospital, Newcastle University, and Newcastle upon Tyne Hospitals NHS Trust, Newcastle, UK.
  • de Winter RJ; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Kogame N; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, Netherlands; Department of Cardiology, Toho University Medical Centre Ohashi Hospital, Tokyo, Japan.
  • Chang CC; Thoraxcenter, Erasmus University Medical Centre, Rotterdam, Netherlands; Cardiology Division, Department of Internal Medicine, Taipei Veterans General Hospital, Taiwan.
  • Modolo R; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, Netherlands; Cardiology Division, Department of Internal Medicine, University of Campinas, Campinas, SP, Brazil.
  • Spitzer E; Thoraxcenter, Erasmus University Medical Centre, Rotterdam, Netherlands; Cardialysis Clinical Trials Management and Core Laboratories, Rotterdam, Netherlands.
  • Tonino P; Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands.
  • Hofma S; Medical Centre Leeuwarden, Leeuwarden, Netherlands.
  • Zurakowski A; Malopolskie Centrum Sercowo-Naczyniowe PAKS, Chrzanow, Poland.
  • Smits PC; Maasstad Ziekenhuis, Rotterdam, Netherlands.
  • Prokopczuk J; PAKS Kedzierzyn, Kozle, Poland.
  • Moreno R; Cardiology Department, La Paz University Hospital, Madrid, Spain.
  • Choudhury A; Department of Cardiology, University Hospital of Wales, Cardiff, UK.
  • Petrov I; Acibadem City Clinic Cardiovascular Center, Sofia, Bulgaria.
  • Cequier A; University Hospital of Bellvitge, Barcelona, Spain.
  • Kukreja N; Department of Cardiology, East and North Hertfordshire NHS Trust, Hertfordshire, UK.
  • Hoye A; Department of Academic Cardiology, University of Hull, Castle Hill Hospital, UK.
  • Iniguez A; Hospital do Meixoeiro, Vigo, Spain.
  • Ungi I; Division of Invasive Cardiology, Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
  • Serra A; Unidad de Cardiología Intervencionista, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Gil RJ; Department of Invasive Cardiology, Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland; Mossakowski Medical Research Centre, Polish Academy of Science, Warsaw, Poland.
  • Walsh S; Department of Cardiology Belfast Health & Social Care Trust, Belfast, UK.
  • Tonev G; Multi-profile Hospital for Active Treatment, St George's University, Plovdiv, Bulgaria.
  • Mathur A; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK.
  • Merkely B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Colombo A; Division of Interventional Cardiology, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.
  • Ijsselmuiden S; Amphia Ziekenhuis, Breda, Netherlands.
  • Soliman O; Thoraxcenter, Erasmus University Medical Centre, Rotterdam, Netherlands; Cardialysis Clinical Trials Management and Core Laboratories, Rotterdam, Netherlands.
  • Kaul U; Academics and Research, Batra Hospital and Medical Research Center, New Delhi, India.
  • Onuma Y; Thoraxcenter, Erasmus University Medical Centre, Rotterdam, Netherlands; Cardialysis Clinical Trials Management and Core Laboratories, Rotterdam, Netherlands. Electronic address: yonuma@cardialysis.nl.
  • Serruys PW; International Centre for Circulatory Health, Imperial College London, London, UK. Electronic address: patrick.w.j.c.serruys@pwserruys.com.
Lancet ; 393(10175): 987-997, 2019 03 09.
Article em En | MEDLINE | ID: mdl-30827782
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sirolimo / Aterosclerose / Stents Farmacológicos / Intervenção Coronária Percutânea / Everolimo / Imunossupressores Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sirolimo / Aterosclerose / Stents Farmacológicos / Intervenção Coronária Percutânea / Everolimo / Imunossupressores Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido